EIM
DSCI

Essex Investment Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Essex Investment Management’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-24,796
Closed -$207K – 392
2014
Q3 		$207K Sell
24,796
-68,262
-73% -$632K 0.03% 327
2014
Q2 		$1.08M Sell
93,058
-23,295
-20% -$239K 0.16% 170
2014
Q1 		$1.48M Buy
116,353
+22,921
+25% +$296K 0.21% 142
2013
Q4 		$1.01M Buy
93,432
+4,080
+5% +$47.4K 0.14% 194
2013
Q3 		$1.11M Sell
89,352
-6,158
-6% -$85.2K 0.17% 168
2013
Q2 		$1.27M Buy
+95,510
New +$1.23M 0.23% 124

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Essex Investment Management's DSCI Position: Q4 2014 in Review

Essex Investment Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q4 2014, closing a stake of 24,796 shares — an estimated $207K sold.

Essex Investment Management first reported a position in DSCI in Q2 2013 and held it in 6 quarters. The position peaked at $1.48M in Q1 2014. 63 funds tracked by Wall St. Rank hold DSCI as of Q4 2014.

  • Essex Investment Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q4 2014 after selling out during the quarter.
  • Essex Investment Management sold 24,796 Derma Sciences, Inc. Common Stock (DE) shares in Q4 2014, an estimated $207K.
  • Essex Investment Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 6 quarters.
  • Essex Investment Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $1.48M in Q1 2014.
  • 63 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q4 2014.

Based on Essex Investment Management's 13F filing for Q4 2014, filed 27 Jan 2015.